Among white non-Hispanics older than 50 years, nonmelanoma skin cancer (NMSC) incidence is likely to exceed 3.5 million annually in the United States.1 From a clinical and public health perspective, identifying the characteristics of those at the highest risk would allow allocating limited resources to screen those most at need. Those with a prior NMSC are known to be at high risk, but data on the magnitude of and patient characteristics related to this risk are particularly important in deciding how these patients should be monitored.
Wu PA, Stern RS. How Likely Is Another Nonmelanoma Skin Cancer? Better Informing Patients and Clinicians. JAMA Dermatol. 2015;151(4):369–370. doi:10.1001/jamadermatol.2014.3827
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.